1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
(
- Contribution to journal › Article
- 2011
-
Mark
Genetic and Epigenetic Characterisation of Breast Tumours
(
- Thesis › Doctoral thesis (compilation)